BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33955314)

  • 21. Demographic, clinical and hormonal characteristics of patients with premature ovarian insufficiency and those of early menopause: data from two tertiary premature ovarian insufficiency centers in Greece.
    Bompoula MS; Valsamakis G; Neofytou S; Messaropoulos P; Salakos N; Mastorakos G; Kalantaridou SN
    Gynecol Endocrinol; 2020 Aug; 36(8):693-697. PubMed ID: 32208770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary ovarian insufficiency: a toolkit for the busy clinician.
    Kapoor E
    Menopause; 2024 Jan; 31(1):65-67. PubMed ID: 38086010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Premature ovarian insufficiency - patients are underdiagnosed and undertreated].
    Norling A; Lindstrand A; Hirschberg A
    Lakartidningen; 2020 Feb; 117():. PubMed ID: 32096868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone and heart health in menopause.
    Nash Z; Al-Wattar BH; Davies M
    Best Pract Res Clin Obstet Gynaecol; 2022 May; 81():61-68. PubMed ID: 35400590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment.
    Cui J; Wang Y
    J Ovarian Res; 2024 Jan; 17(1):8. PubMed ID: 38191456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Müllerian Hormone in the Diagnosis and Prediction of Premature Ovarian Insufficiency.
    Anderson RA; Nelson SM
    Semin Reprod Med; 2020 Sep; 38(4-05):263-269. PubMed ID: 33429444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency.
    Bachelot A; Nicolas C; Gricourt S; Dulon J; Leban M; Golmard JL; Touraine P
    PLoS One; 2016; 11(12):e0164638. PubMed ID: 27906970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Hormonal Replacement Therapy on Bone Mineral Density in Premature Ovarian Insufficiency Patients.
    Podfigurna A; Maciejewska-Jeske M; Nadolna M; Mikolajska-Ptas P; Szeliga A; Bilinski P; Napierala P; Meczekalski B
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women with primary ovarian insufficiency have lower bone mineral density.
    Amarante F; Vilodre LC; Maturana MA; Spritzer PM
    Braz J Med Biol Res; 2011 Jan; 44(1):78-83. PubMed ID: 21085897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Ovarian Insufficiency and Ovarian Aging.
    Verrilli L
    Obstet Gynecol Clin North Am; 2023 Dec; 50(4):653-661. PubMed ID: 37914485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premature ovarian insufficiency: the context of long-term effects.
    Podfigurna-Stopa A; Czyzyk A; Grymowicz M; Smolarczyk R; Katulski K; Czajkowski K; Meczekalski B
    J Endocrinol Invest; 2016 Sep; 39(9):983-90. PubMed ID: 27091671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Noncoding RNA in the Pathophysiology and Treatment of Premature Ovarian Insufficiency.
    Pankiewicz K; Laudański P; Issat T
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introducing a value-based healthcare approach for women with premature ovarian insufficiency (POI): Recommendations for patient-centered outcomes in clinical practice.
    van Zwol-Janssens C; Jiskoot G; Schipper J; Louwers YV
    Maturitas; 2024 Jun; 184():107971. PubMed ID: 38492525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Efficacy of Long-Term Estrogen Replacement Therapy in Turner Syndrome Women with Premature Ovarian Insufficiency.
    Son KA; Lee DY; Yoon BK; Choi D
    J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):530-534. PubMed ID: 31145987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of bone health in women with premature ovarian insufficiency: Systematic appraisal of clinical practice guidelines and algorithm development.
    Kiriakova V; Cooray SD; Yeganeh L; Somarajah G; Milat F; Vincent AJ
    Maturitas; 2019 Oct; 128():70-80. PubMed ID: 31561827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying and addressing osteoporosis knowledge gaps in women with premature ovarian insufficiency and early menopause: A mixed-methods study.
    Goh M; Nguyen HH; Khan NN; Milat F; Boyle JA; Vincent AJ
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):498-507. PubMed ID: 31218708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility desires, choice of hormone replacement and the effect of length of time since menopause on bone density in women with premature ovarian insufficiency: a review of 223 consecutive new referrals to a tertiary centre.
    Mittal M; Kreatsa M; Narvekar N; Savvas M; Hamoda H
    Post Reprod Health; 2014 Sep; 20(3):104-11. PubMed ID: 24973049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCAA insufficiency leads to premature ovarian insufficiency via ceramide-induced elevation of ROS.
    Guo X; Zhu Y; Guo L; Qi Y; Liu X; Wang J; Zhang J; Cui L; Shi Y; Wang Q; Liu C; Lu G; Liu Y; Li T; Hong S; Qin Y; Xiong X; Wu H; Huang L; Huang H; Gu C; Li B; Li J
    EMBO Mol Med; 2023 Apr; 15(4):e17450. PubMed ID: 36847712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
    Armeni E; Paschou SA; Goulis DG; Lambrinoudaki I
    Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101561. PubMed ID: 34274232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ESHRE Guideline: management of women with premature ovarian insufficiency.
    ; Webber L; Davies M; Anderson R; Bartlett J; Braat D; Cartwright B; Cifkova R; de Muinck Keizer-Schrama S; Hogervorst E; Janse F; Liao L; Vlaisavljevic V; Zillikens C; Vermeulen N
    Hum Reprod; 2016 May; 31(5):926-37. PubMed ID: 27008889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.